Published in

Elsevier, Clinical Biochemistry, (61), p. 34-39, 2018

DOI: 10.1016/j.clinbiochem.2018.08.012

Links

Tools

Export citation

Search in Google Scholar

IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO